Updated 2026-08-12 · NCT07218354See eligibility →
City
Clinical trials near Palo Alto, United States
Active studies with a listed research site in Palo Alto, United States.
10active studies
6recruiting now
1countries represented
19largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 4
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Updated 2026-04-20 · NCT06657209See eligibility →
Recruiting nowNot applicable
CHIME: Comparing Health Interventions for Maternal Equity
Updated 2026-03-05 · NCT06724172See eligibility →
Recruiting nowNot applicable
Stanford Pediatric Healthy Weight Index
Updated 2026-01-05 · NCT07316816See eligibility →
Recruiting nowNot applicable
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
Updated 2024-12-04 · NCT05833217See eligibility →
Updated 2024-12-04 · NCT05912621See eligibility →
Opening soonNot applicable
Reset: Enhancing Weight Loss in a Digital Intervention
Updated 2026-08-04 · NCT07032571See eligibility →
Opening soonNot applicable
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Updated 2026-05-28 · NCT07601061See eligibility →
Active, not recruitingNot applicable
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
Updated 2025-08-29 · NCT05874635See eligibility →
Active, not recruitingNot applicable
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
Updated 2025-08-24 · NCT05121844See eligibility →
Related cities
Beijing, China123Boston, United States76Houston, United States75Shanghai, China74Chicago, United States70New York, United States59
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.